Related Experiment Video

Updated: Feb 14, 2026

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model
05:52

Myocardial Infarction by Percutaneous Embolization Coil Deployment in a Swine Model

Published on: November 4, 2021

3.4K

[Myocardial Infarction Due to Coronary Artery Embolism]

V N Manchurov1, K V Anisimov2, M B Oskanov2

  • 1Federal State Budgetary Educational Institution of Higher Education, "A. I. Evdokimov Moscow State University for Medicine and Dentistry" of the Ministry of Health of the Russian Federation.

Kardiologiia
|February 22, 2018
PubMed

Insights

Coronary artery embolism (CAE) is a key non-atherosclerotic cause of acute myocardial infarction (AMI). This review synthesizes data on embolic AMI and presents novel treatment approaches for CAE.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Medical Diagnostics

Background:

  • Coronary artery embolism (CAE) is a significant, yet often overlooked, non-atherosclerotic cause of acute myocardial infarction (AMI).
  • Diagnostic challenges and a lack of evidence-based management guidelines complicate the clinical approach to CAE.
  • Understanding the distinct features of embolic AMI is crucial for timely and effective intervention.

Purpose of the Study:

  • To synthesize current data and knowledge regarding embolic acute myocardial infarction.
  • To highlight the diagnostic difficulties associated with CAE.
  • To present novel therapeutic strategies through case reports.

Main Methods:

  • Comprehensive literature review of studies on coronary artery embolism and embolic AMI.
  • Analysis of clinical features, diagnostic methods, and treatment outcomes for CAE.
  • Retrospective analysis of three patient cases with CAE, focusing on innovative treatment approaches.

Main Results:

  • CAE presents unique diagnostic challenges compared to atherosclerotic causes of AMI.
  • Current management strategies for CAE are not well-defined by evidence-based guidelines.
  • The presented cases illustrate potential new treatment avenues for embolic AMI.

Conclusions:

  • Coronary artery embolism is an important differential diagnosis in non-atherosclerotic AMI.
  • Further research is needed to establish clear diagnostic criteria and evidence-based treatment guidelines for CAE.
  • Novel treatment approaches may offer improved outcomes for patients with embolic AMI.

Keywords:
coronary embolismmyocardial infarction

More Related Videos

Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction05:48

Left Coronary Artery Ligation: A Surgical Murine Model of Myocardial Infarction

Published on: August 9, 2022

5.4K
Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery08:38

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery

Published on: August 16, 2019

29.6K

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
540
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
303
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
424
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
735
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
793